Professor Dr Shah Nawaz Khan possesses a long experience in clinical practice,teaching and research since 1964. He did his PhD from University of London , the Middlesex Hospital Medical School, London in 1985. Earlier he had obtained M.Phil from Basic Medical Sciences Institute, Jinnah Postgraduate Medical Centre, University of Karachi in 1978. His M/Phil research on Ischaemic Heart Disease and Hypertension at the National Institute of Cardiovascular Diseases, Karachi, was appreciated highly by leading Cardiologists & Scientists in the meetings of Pakistan Society of Cardiology , which prompted him to get his research presented at international meetings in Japan and USA. The work was published in reputed journals such as Pakistan Heart Journal (1979) and Clinical Chemistry (USA) 1984.
Dr Khan worked as Research Associate and Assistant Professor at the UCL-Middlesex Hospital School of Medicine, University of London during 1981 – 1985. Simultaneously, he was associated with the Platelet Research Group at the Royal College of Surgeons of England, Lincoln’s Inn Fields, London as well as National Hospital, Queens Square, London. Dr. Khan made original discoveries about the underlying mechanisms of formation of blood clots and platelet aggregates in the circulation. He discovered the inhibitors of highly potent platelet aggregating agent, PAF-acether and using that inhibitor, the mechanisms involved in platelet activation were studied. He also discovered the phenomenon of disaggregation of aggregated blood platelets and reversal brought about by the specific anti platelet drugs. His findings through electron microscopy and sub-cellular molecular level research were presented at many international conferences in UK , France, Sweden and USA.
Dr. Khan’s original work also won him European AGNES OGDEN PRIZE in 1987 Many world reknown scientists appreciated the achievements of Dr Khan through personal letters & requests for reprints. Among many , the two names - the Nobel Prize winner, Professor Sir John Vane and the Princess Anne, the Royal Princess and Chancellor of University of London are worth mentioning, who personally visited him and appreciated his research in high scientific gatherings.
The areas of research interests of Dr.Shah Nawaz Khan include cardiovascular diseases, Thrombosis, Bloodomics, Endocrine disorders, Multiple Sclerosis and noso comial infections.
Dr Khan also worked as a Consultant and specialist of Metabolic Medicine for 10 years in Saudi Arabia , he was the Provincial Chief of Program for diagnosing and Treatment of Endocrine disorders in the New-born & growing children. He introduced Hospital Infection Control and organized Continued Medical Education and Research for doctors & medical Staff in Hospitals of Tabuk Province under the Ministry of Health, KSA.
In 1998, he again proceeded to USA, where he was the Director & Organizer of Polytech Research in the field of Biotechnology in California He was in the process of Setting up a multi disciplinary research institute in California when the 9-11(September 11, 2001) events happened disturbing the Muslims world over and particularly those in USA.
Dr Shah Nawaz Khan’s research contributions are well known in Europe and USA. He has 30 original research papers & theses -published in prestigious journals like British Journal of Pharmacology, European Journal of Pharmacology, Journal de Pharmacol (Paris), Clinical Chemistry (USA), Acta Neurol Scandinavia (Sweden), PLATELET (USA), Progresses Lipid Research (USA)) , Pakistan Heart Journal.
After arrival from USA back to Pakistan in 2002, he has been contributing his services to the Medical Colleges & Universities of Pakistan. He is a recognized Eminent Scientist and Professor of Pathology as well as the Supervisor for PhD by the Higher Education Commission of Pakistan. His experience in England, Saudi Arabia as well as in Pakistan is recognized by the PMDC.
Dr. Khan has a strong desire to get the levels of medical research in Pakistan upgraded & raised higher to the levels in Europe and USA through hard work and original scientific achievements.
